Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Peringkat dalam Saham
#3628
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Harga Saham
$3.71
Kapitalisasi Pasar
$4.69B
Perubahan (1 hari)
2.44%
Perubahan (1 tahun)
-51.92%
Negara
CN
Perdagangan Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Kategori
Healthcare
Margin Operasi untuk Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Margin Operasi per October 2026 TTM: -22.69%
Menurut laporan keuangan dan harga saham terbaru dari Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., margin operasi saat ini (TTM) adalah -22.69%. Pada akhir 2023, margin operasi perusahaan adalah 25.43%.
Riwayat margin operasi untuk Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. dari 2013 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Mengubah |
|---|---|---|
| 2026 (TTM) | -22.69% | -642.82% |
| 2024 | 4.18% | -83.56% |
| 2023 | 25.43% | -49.17% |
| 2022 | 50.03% | 23.56% |
| 2021 | 40.49% | 22.96% |
| 2020 | 32.93% | 78.58% |
| 2019 | 18.44% | -37.32% |
| 2018 | 29.42% | 56.32% |
| 2017 | 18.82% | 20.87% |
| 2016 | 15.57% | -13.02% |
| 2015 | 17.90% | -7.40% |
| 2014 | 19.33% | 0.26% |
| 2013 | 19.28% | 0.00% |
Margin Operasi untuk perusahaan sejenis atau pesaing
| Perusahaan | Margin Operasi | Perbedaan Margin Operasi | Negara |
|---|---|---|---|
| 38.59% | -101.70% |
US
|
|
| -149.01% | -93.43% |
US
|
|
| 25.57% | -101.13% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -101.27% |
NL
|
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.